BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 27987128)

  • 1. The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside.
    Hu J; Chen Q
    Int Urol Nephrol; 2017 Mar; 49(3):369-380. PubMed ID: 27987128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen-glucocorticoid interactions in the era of novel prostate cancer therapy.
    Narayanan S; Srinivas S; Feldman D
    Nat Rev Urol; 2016 Jan; 13(1):47-60. PubMed ID: 26643568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids and prostate cancer treatment: friend or foe?
    Montgomery B; Cheng HH; Drechsler J; Mostaghel EA
    Asian J Androl; 2014; 16(3):354-8. PubMed ID: 24625881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid receptor alpha, beta and gamma expression vs in vitro glucocorticod resistance in childhood leukemia.
    Haarman EG; Kaspers GJ; Pieters R; Rottier MM; Veerman AJ
    Leukemia; 2004 Mar; 18(3):530-7. PubMed ID: 14724649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of glucocorticoid receptor isoforms expression in acute lymphoblastic leukemia correlate with glucocorticoid resistance.
    Sun X; Fang M; Guan Y; Si Y; Ma L; Wang Y; Jia Z
    Pharmazie; 2015 May; 70(5):316-21. PubMed ID: 26062300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid receptor signaling and prostate cancer.
    Kassi E; Moutsatsou P
    Cancer Lett; 2011 Mar; 302(1):1-10. PubMed ID: 21078539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corticotherapy in castration-resistant prostate cancer].
    Lebdai S; Branchereau J; Robert G; De La Taille A; Bouchaert P
    Prog Urol; 2013 Oct; 23 Suppl 1():S23-33. PubMed ID: 24314736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Glucocorticoid Receptor Is a Key Player for Prostate Cancer Cell Survival and a Target for Improved Antiandrogen Therapy.
    Puhr M; Hoefer J; Eigentler A; Ploner C; Handle F; Schaefer G; Kroon J; Leo A; Heidegger I; Eder I; Culig Z; Van der Pluijm G; Klocker H
    Clin Cancer Res; 2018 Feb; 24(4):927-938. PubMed ID: 29158269
    [No Abstract]   [Full Text] [Related]  

  • 9. Lung cancer metastasis-related protein 1 promotes the transferring from advanced metastatic prostate cancer to castration-resistant prostate cancer by activating the glucocorticoid receptor α signal pathway.
    Wang K; Wang X; Fu X; Sun J; Zhao L; He H; Fan Y
    Bioengineered; 2022 Mar; 13(3):5373-5385. PubMed ID: 35184651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of glucocorticoid receptor is negatively regulated by active androgen receptor signaling in prostate tumors.
    Xie N; Cheng H; Lin D; Liu L; Yang O; Jia L; Fazli L; Gleave ME; Wang Y; Rennie P; Dong X
    Int J Cancer; 2015 Feb; 136(4):E27-38. PubMed ID: 25138562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of glucocorticoid receptor alpha isoform in adult immune thrombocytopenia correlates with glucocorticoid resistance.
    Ma L; Fang M; Liang Y; Xiang Y; Jia Z; Sun X; Wang Y; Qin J
    Ann Hematol; 2013 Jul; 92(7):953-60. PubMed ID: 23435844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [ASC-J9 for castration-resistant prostate cancer].
    Yamashita S; Arai Y
    Nihon Rinsho; 2014 Dec; 72(12):2126-9. PubMed ID: 25518345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the glucocorticoid receptor a key player in prostate cancer?: A literature review.
    Sakellakis M; Flores LJ
    Medicine (Baltimore); 2022 Jul; 101(29):e29716. PubMed ID: 35866830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of glucocorticoid receptor isoforms and associations with serine/arginine-rich protein 30c and 40 in patients with systemic lupus erythematosus.
    Guan YC; Jiang L; Ma LL; Sun XN; Yu DD; Liu J; Qu DX; Fang MY
    Clin Exp Rheumatol; 2015; 33(2):225-33. PubMed ID: 25665148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Qualitative and quantitative hormonal regulation in castration-resistant prostate cancer].
    Murez T; Basset V; Audenet F; Lebret T; Branchereau J
    Prog Urol; 2013 Oct; 23 Suppl 1():S1-8. PubMed ID: 24314734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between expression of glucocorticoid receptor isoforms and glucocorticoid resistance in immune thrombocytopenia.
    Liang Y; Song MM; Liu SY; Ma LL
    Hematology; 2016 Aug; 21(7):440-6. PubMed ID: 27077774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploitation of the Androgen Receptor to Overcome Taxane Resistance in Advanced Prostate Cancer.
    Martin SK; Kyprianou N
    Adv Cancer Res; 2015; 127():123-58. PubMed ID: 26093899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biology of castration-resistant prostate cancer].
    Doucet L; Terrisse S; Gauthier H; Pouessel D; Le Maignan C; Teixeira L; Culine S
    Bull Cancer; 2015 Jun; 102(6):497-500. PubMed ID: 26028493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leading causes of castration-resistant prostate cancer.
    Lu M; Lu H; Kong Q
    Expert Rev Anticancer Ther; 2015 Apr; 15(4):425-32. PubMed ID: 25645203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.